CURLF 8-K 2026-11-03

Curaleaf Holdings, Inc. (CURLF) 8-K dated 2026-11-03 — accession 0001628280-26-069455.

Curaleaf Holdings, Inc. (CURLF) is a drug manufacturers - specialty & generic company listed on US.

Curaleaf Holdings, Inc. filed a 8-K on 2026-11-03. Accession 0001628280-26-069455.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported CURLF revenue for 2025-12-31 was $1.27B. Net income was -$231.1M. Revenue was down 5.6% from 2024-12-31 to 2025-12-31. CURLF currently screens at market cap $628.9M.

Not investment advice. The CURLF SEC hub lists recent forms. The stock page is the research view.